415 related articles for article (PubMed ID: 9039114)
1. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
Hypertension; 1997 Jan; 29(1 Pt 2):274-9. PubMed ID: 9039114
[TBL] [Abstract][Full Text] [Related]
2. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
Circulation; 1998 Jun; 97(22):2222-9. PubMed ID: 9631871
[TBL] [Abstract][Full Text] [Related]
3. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension.
Taddei S; Virdis A; Mattei P; Natali A; Ferrannini E; Salvetti A
Circulation; 1995 Nov; 92(10):2911-8. PubMed ID: 7586259
[TBL] [Abstract][Full Text] [Related]
4. beta-Adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: restoration by L-arginine.
Schlaich MP; Ahlers BA; Parnell MM; Kaye DM
J Hypertens; 2004 Oct; 22(10):1917-25. PubMed ID: 15361763
[TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide towards vasodilator effects of substance P and ATP in human forearm vessels.
Shiramoto M; Imaizumi T; Hirooka Y; Endo T; Namba T; Oyama J; Hironaga K; Takeshita A
Clin Sci (Lond); 1997 Feb; 92(2):123-31. PubMed ID: 9059312
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women.
Virdis A; Ghiadoni L; Pinto S; Lombardo M; Petraglia F; Gennazzani A; Buralli S; Taddei S; Salvetti A
Circulation; 2000 May; 101(19):2258-63. PubMed ID: 10811592
[TBL] [Abstract][Full Text] [Related]
7. Age-related reduction of NO availability and oxidative stress in humans.
Taddei S; Virdis A; Ghiadoni L; Salvetti G; Bernini G; Magagna A; Salvetti A
Hypertension; 2001 Aug; 38(2):274-9. PubMed ID: 11509489
[TBL] [Abstract][Full Text] [Related]
8. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation.
Gilligan DM; Panza JA; Kilcoyne CM; Waclawiw MA; Casino PR; Quyyumi AA
Circulation; 1994 Dec; 90(6):2853-8. PubMed ID: 7994830
[TBL] [Abstract][Full Text] [Related]
9. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension.
Panza JA; Casino PR; Kilcoyne CM; Quyyumi AA
Circulation; 1993 May; 87(5):1468-74. PubMed ID: 8491001
[TBL] [Abstract][Full Text] [Related]
10. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway.
Panza JA; García CE; Kilcoyne CM; Quyyumi AA; Cannon RO
Circulation; 1995 Mar; 91(6):1732-8. PubMed ID: 7882481
[TBL] [Abstract][Full Text] [Related]
11. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Favilla S; Pompella A; Salvetti A
Hypertension; 2001 Mar; 37(3):943-8. PubMed ID: 11244022
[TBL] [Abstract][Full Text] [Related]
12. Role of nitric oxide in adenosine-induced vasodilation in humans.
Costa F; Biaggioni I
Hypertension; 1998 May; 31(5):1061-4. PubMed ID: 9576114
[TBL] [Abstract][Full Text] [Related]
13. Effect of potassium on vasodilation to acetylcholine in essential hypertension.
Taddei S; Mattei P; Virdis A; Sudano I; Ghiadoni L; Salvetti A
Hypertension; 1994 Apr; 23(4):485-90. PubMed ID: 8144217
[TBL] [Abstract][Full Text] [Related]
14. Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients.
Taddei S; Ghiadoni L; Virdis A; Buralli S; Salvetti A
Circulation; 1999 Sep; 100(13):1400-5. PubMed ID: 10500040
[TBL] [Abstract][Full Text] [Related]
15. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients.
Taddei S; Virdis A; Mattei P; Ghiadoni L; Sudano I; Salvetti A
Circulation; 1996 Sep; 94(6):1298-303. PubMed ID: 8822983
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandins are involved in acetylcholine- and 5-hydroxytryptamine-induced, nitric oxide-mediated vasodilatation in human forearm.
Kamper AM; Paul LC; Blauw GJ
J Cardiovasc Pharmacol; 2002 Dec; 40(6):922-9. PubMed ID: 12451326
[TBL] [Abstract][Full Text] [Related]
17. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients.
Casino PR; Kilcoyne CM; Quyyumi AA; Hoeg JM; Panza JA
Circulation; 1993 Dec; 88(6):2541-7. PubMed ID: 8252665
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients.
Giannarelli C; De Negri F; Virdis A; Ghiadoni L; Cipriano A; Magagna A; Taddei S; Salvetti A
Hypertension; 2007 Apr; 49(4):878-84. PubMed ID: 17339540
[TBL] [Abstract][Full Text] [Related]
19. Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension.
Cardillo C; Kilcoyne CM; Quyyumi AA; Cannon RO; Panza JA
Circulation; 1998 Mar; 97(9):851-6. PubMed ID: 9521333
[TBL] [Abstract][Full Text] [Related]
20. Forearm blood flow responses to a nitric oxide synthase inhibitor in patients with treated essential hypertension.
Calver A; Collier J; Vallance P
Cardiovasc Res; 1994 Nov; 28(11):1720-5. PubMed ID: 7531114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
